Literature DB >> 18359724

Potential roles for pharmacists in pharmacogenetics.

Shareen Y El-Ibiary1, Christine Cheng, Brian Alldredge.   

Abstract

OBJECTIVES: To highlight areas of pharmacogenetics in which pharmacists may play a role and to describe those roles in the context of specific examples from a major academic medical center. DATA SOURCES: Literature search (PubMed) and personal interviews for the University of California at San Francisco case examples. DATA SYNTHESIS: The field of pharmacogenetics presents a wide range of opportunities for pharmacists. Specific roles for pharmacists are likely to fall within three major domains: developing research methodologies and setting research directions, establishing the value of pharmacogenetic testing in clinical practice, and participating in education and infrastructure development that moves pharmacogenetic technologies toward implementation.
CONCLUSION: As drug therapy experts, pharmacists are in a unique position to push the frontiers of pharmacogenetics in both the research and clinical practice environments.

Mesh:

Year:  2008        PMID: 18359724     DOI: 10.1331/JAPhA.2008.07050

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  16 in total

1.  Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.

Authors:  Sony Tuteja; Kevin Haynes; Cara Zayac; Jon E Sprague; Barbara Bernhardt; Reed Pyeritz
Journal:  Per Med       Date:  2013-11       Impact factor: 2.512

Review 2.  Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors:  Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal:  Patient Educ Couns       Date:  2014-06-21

3.  Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge.

Authors:  Louai Alsaloumi; Abdikarim Abdi; Özgür Tosun; Bilgen Başgut
Journal:  Int J Clin Pharm       Date:  2019-07-02

4.  On the readiness of physicians for pharmacogenomics testing: an empirical assessment.

Authors:  N Amara; J Blouin-Bougie; D Bouthillier; J Simard
Journal:  Pharmacogenomics J       Date:  2017-06-13       Impact factor: 3.550

5.  Development and evaluation of a pharmacogenomics educational program for pharmacists.

Authors:  Christine M Formea; Wayne T Nicholson; Kristen B McCullough; Kevin D Berg; Melody L Berg; Julie L Cunningham; Julianna A Merten; Narith N Ou; Joanna L Stollings
Journal:  Am J Pharm Educ       Date:  2013-02-12       Impact factor: 2.047

6.  The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group.

Authors:  Mary Jayne Kennedy; Hanna Phan; Sandra Benavides; Amy Potts; Susan Sorensen
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

7.  Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.

Authors:  Katrina M Romagnoli; Richard D Boyce; Philip E Empey; Solomon Adams; Harry Hochheiser
Journal:  Int J Med Inform       Date:  2015-11-30       Impact factor: 4.046

8.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

9.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

10.  CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention.

Authors:  Melissa Mejin; Wen Ni Tiong; Lana Yin Hui Lai; Lee Len Tiong; Adam Mohamad Bujang; Siaw San Hwang; Tiong Kiam Ong; Alan Yean Yip Fong
Journal:  Int J Clin Pharm       Date:  2013-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.